Vivo Ventures Fund VI, L.P. is 10% at Sagent Pharmaceuticals, Inc. (SGNT). They have made 3 open-market trades across 3 companies since 2009, most recently 2016-08-18.
CIK 0001469473
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2016, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.